Squarepoint Ops LLC Silverback Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	N/A	71,905 Added 557.27%	84,808 $0
Q1 2023 May 15, 2023	BUY	N/A	12,903 New	12,903 $0
Q4 2021 Feb 14, 2022	SELL	$6.03 - $11.67 $94,025 - $181,970	-15,593 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.98 - $35.22 $64,790 - $228,648	6,492 Added 71.33%	15,593 $156,000
Q2 2021 Aug 16, 2021	BUY	$24.71 - $44.28 $224,885 - $402,992	9,101 New	9,101 $281,000

122

61.4M

1.37M

83.8K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.